Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

about

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

Item

http://www.wikidata.org/entity/Q52664057

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

@en

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

@nl

type

Item

label

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

@en

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

@nl

prefLabel

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

@en

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

@nl

P1476

Low dose Naltrexone for induction of remission in inflammatory bowel disease patients.

@en

P2093

Alison de Lima

http://www.w3.org/2001/XMLSchema#string

C Janneke van der Woude

http://www.w3.org/2001/XMLSchema#string

Cokkie van der Ent

http://www.w3.org/2001/XMLSchema#string

Gwenny M Fuhler

http://www.w3.org/2001/XMLSchema#string

Janine van der Giessen

http://www.w3.org/2001/XMLSchema#string

Mitchell R K L Lie

http://www.w3.org/2001/XMLSchema#string

P2860

XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease

Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study

An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study

Low-dose naltrexone therapy improves active Crohn's disease

A functional CFTR assay using primary cystic fibrosis intestinal organoids

Violacein induces death of resistant leukaemia cells via kinome reprogramming, endoplasmic reticulum stress and Golgi apparatus collapse

The unfolded protein response in immunity and inflammation

Genomic ATG16L1 risk allele-restricted Paneth cell ER stress in quiescent Crohn's disease.

Safety and tolerability of low-dose naltrexone therapy in children with moderate to severe Crohn's disease: a pilot study

Evaluation of therapeutic effect of low dose naltrexone in experimentally-induced Crohn's disease in rats.

P2888

s12967-018-1427-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-018-1427-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Maikel P Peppelenbosch

P577

2018-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101395044

http://www.w3.org/2001/XMLSchema#string

P698

29523156

http://www.w3.org/2001/XMLSchema#string

P921

naltrexone

Low-dose naltrexone

P932

5845217

http://www.w3.org/2001/XMLSchema#string